ReviewJournal of the Chinese Medical Association : JCMA2026
Surgical treatment of pulsatile tinnitus arising from sigmoid sinus wall anomalies.
Review in Journal of the Chinese Medical Association : JCMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulsatile tinnitus (PT) caused by sigmoid sinus (SS) wall anomalies, most commonly diverticulum and dehiscence, represents a prevalent and potentially reversible venous etiology. This narrative review summarizes contemporary concepts in diagnosis and treatment and proposes a practical framework for clinical decision-making. The characteristic features of venous-type PT are first outlined, with emphasis on strict clinicoradiologic correlation using high-resolution temporal bone computed tomography and magnetic resonance venography to distinguish SS wall abnormalities from other vascular causes, such as dural arteriovenous fistulas (AVFs), high-riding jugular bulbs, and idiopathic intracranial hypertension. Patient selection, contraindications, and clinical "red flags" are then discussed, with particular attention to scenarios in which transmastoid surgery may be ineffective or pose substantial risk and in which systemic therapy or venous sinus stenting should be prioritized. The main transmastoid strategies include sinus wall resurfacing, tailored re-roofing with autologous bone, and diverticulectomy with multilayer reconstruction. These strategies are compared with endovascular approaches in terms of their technical principles, indications, and reported outcomes. Particular attention is given to reconstructive materials, such as polymethylmethacrylate cement, hydroxyapatite, and bone grafts, with consideration of their short- to midterm performance and the current limitations of evidence regarding long-term durability. Integrating these considerations, a stepwise algorithm is proposed to guide the selection of conservative, surgical, or endovascular treatment based on symptom profiles and imaging findings. In carefully selected patients, these strategies can achieve high rates of PT improvement and meaningful gains in quality of life, while highlighting the need for prospective outcome studies with long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.